A case control investigation of COVID-19 associated mucormycosis in India

BACKGROUND: Increased occurrence of mucormycosis during the second wave of COVID-19 pandemic in early 2021 in India prompted us to undertake a multi-site case–control investigation. The objectives were to examine the monthly trend of COVID-19 Associated Mucormycosis (CAM) cases among in-patients and...

Descripción completa

Detalles Bibliográficos
Autores principales: Anand, Tanu, Mukherjee, Aparna, Satija, Aanchal, Velamuri, Poonam Sharma, Singh, Kh. Jitenkumar, Das, Madhuchhanda, Josten, Kripa, Yadav, Pragya D., Sahay, Rima R., Keche, Archana Y., Nagarkar, Nitin M., Gupta, Prashant, Himanshu, D., Mistry, Sejal N., Patel, Jimy D., Rao, Prajwal, Rohatgi, Shalesh, Ghosh, Soumitra, Hazra, Avijit, Kindo, Anupma Jyoti, Annamalai, Radha, Rudramurthy, Shivaprakash M., Singh, Mini P., Shameem, Mohammad, Fatima, Nazish, Khambholja, Janakkumar R., Parikh, Sangita, Madkaikar, Manisha, Pradhan, Vandana D., Kataria, Sushila, Sharma, Pooja, Panda, Samiran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667849/
https://www.ncbi.nlm.nih.gov/pubmed/36384482
http://dx.doi.org/10.1186/s12879-022-07844-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667849/
https://www.ncbi.nlm.nih.gov/pubmed/36384482
http://dx.doi.org/10.1186/s12879-022-07844-y

Ejemplares similares